FDA Commissioner Marty Makary, M.D., took aim at drugmakers, online pharmacies and social media influencers in a new op-ed ...

U.S. packaged food makers have rolled out plans to eliminate the use of ingredients such as FD&C colors — a category of ...

Biogen Inc. (NASDAQ: BIIB) is one of the best drug stocks to buy right now. In a report released on September 12, Sumant ...

RFK Jr. and Marty Makary want to regulate pharma ads so they are ‘no longer feasible.’ ...

Former Surgeon General Jerome Adams criticizes RFK Jr.'s HHS leadership, citing loss of trust, delayed crisis response, and ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

President Donald Trump and his team are crowing about the downsizing of the federal bureaucracy, which is set to shrink by ...

Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately.

The next big investing theme of the 2020s is B.I.G. - BofA. Tesla is said to boost output at German plant on stronger sales.

The FDA released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to prescription opioid misuse.

One of the nation's largest drug advertisers is likely working up major changes to its ad strategy in the wake of a federal government crackdown on drug TV commercials.

The Food and Drug Administration appears to be about to weaponize a classic antivax trope against COVID-19 vaccines, the ...